Iberdrola, S.A. IBE.MC
Composite 42/100; the shares have moved about 15% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 24/100 — a strong mark against it.
Income ranks 69/100 — a moderate point in its favour. Momentum ranks 57/100 — a slight point in its favour. Quality ranks 53/100 — a slight point in its favour.
Growth ranks 24/100 — a strong mark against it. Balance-sheet strength ranks 30/100 — a moderate mark against it. Valuation ranks 35/100 — a moderate mark against it.
What the company does Iberdrola is a diversified global utility with 46,177 MW of installed capacity, generating and distributing electricity from renewables (wind, solar, hydro), conventional sources, and green hydrogen. It serves retail and industrial customers across Spain, the UK, US, and Latin America, offering energy services, self-consumption solutions, and electric mobility.
Key financials Reported ROE 10%, ROA 3.8%, and ROCE 8.2%, with gross/operating/net margins of 53.9%/24.5%/15.9%. Revenue grew 9.8% and EPS 68.3%, but profitability metrics and Piotroski F-Score (4/9) suggest moderate financial health. Leverage is high (Debt/Equity 1.00), though interest coverage is 2.66x.
Stock health Momentum is positive over 3m (5.40%), 6m (11.32%), and 12m (39.62%), but RSI(14) at 42.70 indicates no near-term overbought signal. Dividend yield is 2.0% with a payout ratio of 84.9%, signaling sustainability concerns.
Price vs fair value The stock trades at a **PREMIUM of 81.80%** versus our fair-value estimate and a **PREMIUM of 0.47%** versus the 12-month analyst target. - Forward P/E of 21.01 (vs 26.12 trailing) and PEG of 0.86 suggest growth is priced in (Valuation 35.9/100). - Sideravia’s Momentum score (68.9) and 12m return (39.62%) support recent outperformance. - Quality (49.3) and Strength (29.4) scores are average, limiting valuation headroom.
Looking forward Forward PEG (0.86) implies undervaluation relative to growth, but high leverage (Net debt/EBITDA 3.82) and weak Altman Z (1.30) warrant caution. Execution on renewable capacity additions and margin recovery will be key.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.